These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23933872)

  • 1. Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.
    Vellas B; Pahor M; Manini T; Rooks D; Guralnik JM; Morley J; Studenski S; Evans W; Asbrand C; Fariello R; Pereira S; Rolland Y; Abellan van Kan G; Cesari M; Chumlea WC; Fielding R
    J Nutr Health Aging; 2013 Jul; 17(7):612-8. PubMed ID: 23933872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in Frail Older Adults: Recommendations for Research from the ICFSR Task Force 2020.
    Rolland Y; Cesari M; Fielding RA; Reginster JY; Vellas B; Cruz-Jentoft AJ
    J Frailty Aging; 2021; 10(2):168-175. PubMed ID: 33575707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.
    Vellas B; Fielding RA; Bens C; Bernabei R; Cawthon PM; Cederholm T; Cruz-Jentoft AJ; Del Signore S; Donahue S; Morley J; Pahor M; Reginster JY; Rodriguez Mañas L; Rolland Y; Roubenoff R; Sinclair A; Cesari M
    J Frailty Aging; 2018; 7(1):2-9. PubMed ID: 29412436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional Intervention in Sarcopenia: Report from the International Conference on Frailty and Sarcopenia Research Task Force.
    Landi F; Sieber C; Fielding RA; Rolland Y; Guralnik J
    J Frailty Aging; 2018; 7(4):247-252. PubMed ID: 30298173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing Drug Trials for Frailty: ICFSR Task Force 2018.
    Pahor M; Kritchevsky SB; Waters DL; Villareal DT; Morley J; Hare JM; Vellas B
    J Frailty Aging; 2018; 7(3):150-154. PubMed ID: 30095144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically Meaningful Change for Physical Performance: Perspectives of the ICFSR Task Force.
    Guralnik J; Bandeen-Roche K; Bhasin SAR; Eremenco S; Landi F; Muscedere J; Perera S; Reginster JY; Woodhouse L; Vellas B
    J Frailty Aging; 2020; 9(1):9-13. PubMed ID: 32150208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.
    Aisen P; Touchon J; Amariglio R; Andrieu S; Bateman R; Breitner J; Donohue M; Dunn B; Doody R; Fox N; Gauthier S; Grundman M; Hendrix S; Ho C; Isaac M; Raman R; Rosenberg P; Schindler R; Schneider L; Sperling R; Tariot P; Welsh-Bohmer K; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2017; 4(2):116-124. PubMed ID: 29186281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer's Disease Task Force.
    Cummings J; Fox N; Vellas B; Aisen P; Shan G
    J Prev Alzheimers Dis; 2018; 5(2):103-109. PubMed ID: 29616703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty.
    Rodriguez-Mañas L; Araujo de Carvalho I; Bhasin S; Bischoff-Ferrari HA; Cesari M; Evans W; Hare JM; Pahor M; Parini A; Rolland Y; Fielding RA; Walston J; Vellas B
    J Frailty Aging; 2020; 9(1):4-8. PubMed ID: 32150207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia.
    Reginster JY; Cooper C; Rizzoli R; Kanis JA; Appelboom G; Bautmans I; Bischoff-Ferrari HA; Boers M; Brandi ML; Bruyère O; Cherubini A; Flamion B; Fielding RA; Gasparik AI; Van Loon L; McCloskey E; Mitlak BH; Pilotto A; Reiter-Niesert S; Rolland Y; Tsouderos Y; Visser M; Cruz-Jentoft AJ
    Aging Clin Exp Res; 2016 Feb; 28(1):47-58. PubMed ID: 26717937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force.
    Cesari M; Bernabei R; Vellas B; Fielding RA; Rooks D; Azzolino D; Mariani J; Oliva AA; Bhasin S; Rolland Y
    J Frailty Aging; 2022; 11(2):135-142. PubMed ID: 35441189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.
    Kaye J; Aisen P; Amariglio R; Au R; Ballard C; Carrillo M; Fillit H; Iwatsubo T; Jimenez-Maggiora G; Lovestone S; Natanegara F; Papp K; Soto ME; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2021; 8(4):513-519. PubMed ID: 34585227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials on sarcopenia: methodological issues regarding phase 3 trials.
    Abellan van Kan G; Cameron Chumlea W; Gillette-Guyonet S; Houles M; Dupuy C; Rolland Y; Vellas B
    Clin Geriatr Med; 2011 Aug; 27(3):471-82. PubMed ID: 21824558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention trials in Alzheimer's disease: an EU-US task force report.
    Vellas B; Aisen PS; Sampaio C; Carrillo M; Scheltens P; Scherrer B; Frisoni GB; Weiner M; Schneider L; Gauthier S; Gispen-de Wied CC; Hendrix S; Feldman H; Cedarbaum J; Petersen R; Siemers E; Andrieu S; Prvulovic D; Touchon J; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):594-600. PubMed ID: 21925234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DESIGNING DRUG TRIALS FOR SARCOPENIA IN OLDER ADULTS WITH HIP FRACTURE - A TASK FORCE FROM THE INTERNATIONAL CONFERENCE ONFRAILTY AND SARCOPENIA RESEARCH (ICFSR).
    Vellas B; Fielding R; Miller R; Rolland Y; Bhasin S; Magaziner J; Bischoff-Ferrari H
    J Frailty Aging; 2014; 3(4):199-204. PubMed ID: 26380231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to a standardized protocol for measuring grip strength and appropriate cut-off values in adults over 65 years with sarcopenia: a systematic review protocol.
    Fox B; Henwood T; Schaap L; Bruyère O; Reginster JY; Beaudart C; Buckinx F; Roberts H; Cooper C; Cherubini A; dellʼAquilla G; Maggio M; Volpato S
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):50-9. PubMed ID: 26571282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carla Task Force on Sarcopenia: propositions for clinical trials.
    Abellan van Kan G; André E; Bischoff Ferrari HA; Boirie Y; Onder G; Pahor M; Ritz P; Rolland Y; Sampaio C; Studenski S; Visser M; Vellas B
    J Nutr Health Aging; 2009 Oct; 13(8):700-7. PubMed ID: 19657553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults.
    Reginster JY; Beaudart C; Al-Daghri N; Avouac B; Bauer J; Bere N; Bruyère O; Cerreta F; Cesari M; Rosa MM; Cooper C; Cruz Jentoft AJ; Dennison E; Geerinck A; Gielen E; Landi F; Laslop A; Maggi S; Prieto Yerro MC; Rizzoli R; Sundseth H; Sieber C; Trombetti A; Vellas B; Veronese N; Visser M; Vlaskovska M; Fielding RA
    Aging Clin Exp Res; 2021 Jan; 33(1):3-17. PubMed ID: 32737844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.